We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-2.74%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$755M
AUM Growth
-$1.6B
Cap. Flow
-$1.57B
Cap. Flow %
-207.18%
Top 10 Hldgs %
37.89%
Holding
156
New
15
Increased
10
Reduced
69
Closed
62

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$40.1M
2
PLAY icon
Dave & Buster's
PLAY
+$37.7M
3
MU icon
Micron Technology
MU
+$31.9M
4
CORZ icon
Core Scientific
CORZ
+$31M
5
GXO icon
GXO Logistics
GXO
+$12.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$32.9M
2
AMZN icon
Amazon
AMZN
+$31.9M
3
TKO icon
TKO Group
TKO
+$25M
4
SMTC icon
Semtech
SMTC
+$23M
5
EDR
Endeavor Group Holdings, Inc.
EDR
+$22.1M

Sector Composition

Rank Sector Weight
1 Technology 36.86%
2 Healthcare 17.02%
3 Consumer Discretionary 14.31%
4 Communication Services 13.71%
5 Industrials 5.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNRE
76
DELISTED
Sunrise Communications AG American Depositary Shares representing Class A shares
SNRE
$1.16M 0.15%
+26,967
New +$1.23M
BIO icon
77
Bio-Rad Laboratories Class A
BIO
$8.76B
$1.16M 0.15%
3,535
-12,244
-78% -$4.16M
ENFN
78
DELISTED
Enfusion, Inc.
ENFN
$1.11M 0.15%
107,358
-137,787
-56% -$1.33M
HUM icon
79
Humana
HUM
$43.9B
$1.1M 0.15%
+4,345
New +$1.17M
MRVI icon
80
Maravai LifeSciences
MRVI
$972M
$1.02M 0.14%
187,339
-1,900
-1% -$12.2K
TALK icon
81
Talkspace
TALK
$874M
$1.01M 0.13%
325,720
-923,036
-74% -$2.81M
IART icon
82
Integra LifeSciences
IART
$1.28B
$971K 0.13%
42,814
-187,583
-81% -$4.09M
PCG icon
83
PG&E
PCG
$39B
$933K 0.12%
+46,238
New +$941K
TENB icon
84
Tenable Holdings
TENB
$3.47B
$905K 0.12%
22,969
-5,388
-19% -$223K
ACCD
85
DELISTED
Accolade Inc
ACCD
$814K 0.11%
237,881
-1,301,697
-85% -$4.62M
INFA
86
DELISTED
Informatica
INFA
$762K 0.1%
29,372
-6,890
-19% -$180K
DIN icon
87
Dine Brands
DIN
$462M
$681K 0.09%
22,639
-102,047
-82% -$3.28M
PARA
88
DELISTED
Paramount Global Class B
PARA
$657K 0.09%
+62,788
New +$675K
TXMD icon
89
TherapeuticsMD
TXMD
$23.8M
$546K 0.07%
635,222
-1,400
-0.2% -$1.97K
LNSR icon
90
LENSAR
LNSR
$64.5M
$498K 0.07%
55,652
-117,352
-68% -$778K
SMTC icon
91
Semtech
SMTC
$9.65B
$463K 0.06%
7,488
-435,428
-98% -$23M
SNDX icon
92
Syndax Pharmaceuticals
SNDX
$1.7B
$452K 0.06%
34,177
-8,018
-19% -$137K
JACK icon
93
Jack in the Box
JACK
$314M
$429K 0.06%
10,304
-250,426
-96% -$11.6M
CFLT
94
DELISTED
Confluent
CFLT
$272K 0.04%
9,742
-2,285
-19% -$61.3K
ACHC icon
95
Acadia Healthcare
ACHC
$2.52B
-211,332
Closed -$13.4M
API
96
Agora
API
$333M
-127,974
Closed -$308K
ARRY icon
97
Array Technologies
ARRY
$740M
-852,794
Closed -$5.63M
ATMU icon
98
Atmus Filtration Technologies
ATMU
$4.12B
-192,249
Closed -$7.22M
BILL icon
99
BILL Holdings
BILL
$4.72B
-82,811
Closed -$4.37M
BL icon
100
BlackLine
BL
$1.9B
-34,610
Closed -$1.91M

Similar funds

Clearline Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Clearline Capital held 156 positions worth $755M, down 68% from $2.36B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Clearline Capital withdrew a net $1.57B in Q4 2024, closing 62 positions and reducing 69 holdings. Its most notable exit was NVIDIA, an estimated $32.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Clearline Capital opened a new position in Adobe worth $36M.

  • Clearline Capital's largest Q4 2024 buy was Adobe: 80,905 shares worth $36M.
  • Clearline Capital added most to Dave & Buster's in Q4 2024, an estimated $37.7M increase.
  • Clearline Capital's biggest Q4 2024 reduction was Amazon, cutting an estimated $31.9M.
  • Clearline Capital fully exited NVIDIA in Q4 2024, selling an estimated $32.9M.
  • Clearline Capital's ten largest holdings make up 38% of its $755M portfolio in Q4 2024.
  • Clearline Capital opened 15 new positions and closed 62 in Q4 2024.
  • Clearline Capital's portfolio value fell 68% quarter-over-quarter to $755M.

Based on Clearline Capital's 13F filing for Q4 2024, filed 14 Feb 2025.